Navigation Links
American and European Parkinson's Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
Date:10/8/2007

Westerners Return from Beijing's World-Class Stem Cell Treatment Hospital

with Clear Improvement, Giving Hope Not Found at Home

BEIJING, Oct. 8 /PRNewswire-USNewswire/ -- Tiantan Puhua Neurosurgical Hospital, the world's leading center for effective treatment of Parkinson's disease using adult retinal stem cells, today here announced that four more international patients returned home from China with a significant reduction in their debilitating Parkinson's disease symptoms. These success stories clearly demonstrate stem cells can effectively be used to treat afflictions like Parkinson's in addition to many other neurological disorders. More details and videos of the four patients' progress can be found at http://www.stemcellschina.com.

While debates over stem cells continue in many countries, Western clinical trials have so far found the use of adult retinal stem cells to be the best chance for Parkinson's sufferers to gain a better quality of life. Chinese neurologists at Tiantan Puhua Hospital are among those worldwide leading the implementation of this cutting-edge science through safe and effective treatment. Following Penny Thomas of Hawaii, who benefited from the hospital's stem cell treatment a year ago, four more patients have now come home to better lives in the United States and Europe after treatment at Tiantan Puhua Hospital in Beijing.

Jane Edwards, a 55-year-old United Kingdom citizen, saw comparatively dramatic improvement in her debilitating Parkinson's symptoms almost immediately after a minimally invasive injection that implanted millions of high-quality adult hRPE (human Retinal Pigment Epithelial) cells. The procedure utilizes the latest stereotactic technology. This cutting edge three-dimensional imaging system assists doctors in locating the most appropriate area of the brain or other nerve center to implant the cells. Tiantan Puhua's several weeks treatment program for Parkinson's sufferers also often includes a nutritious intravenous (IV) cocktail that protects the implanted stem cells, personalized physical therapy, and even complementary traditional Chinese medicine. This all takes place in a hospital whose doctors and staff function under fully international standards. More details on Jane's treatment can be found at http://www.stemcellspuhua.com/articles/article_86716.html.

"I hope everyone suffering from this terrible disease and seeking hope will examine the evidence, and will consider coming to China to seek improvement through these great doctors," said Jane. "Those in the West that urge caution for Parkinson's sufferers who consider going to Beijing, with no evidence to say why, simply aren't going through what I have been going through," she said.

Jane was diagnosed with Parkinson's in the spring of 2001, reaching stage three of the disease (on the Hoehn/Yahr scale) as her symptoms became progressively worse just before the treatment. Before coming to China, Jane could not do the simple things in life on her own that most of us take for granted, such as turning over in bed, getting up from a chair, dressing herself, putting on shoes, or writing - the last of which she had given up more than two years ago. She also could not turn her neck and her speech was becoming increasingly slow. Within 6 weeks after the treatment, almost all of Jane's Parkinson's symptoms were greatly reduced. Jane can now write again, turn over in bed, dress by herself, and even ride a bicycle.

Linda Rouen, 59, from the United States, was diagnosed with Parkinson's 5 years ago. In 2007, Linda decided to come to China for stem cell treatment to seek solutions for her deteriorating condition. To control her symptoms, Linda previously took a high dosage of medications every 2 hours.

"I was a watch keeper. I used to watch the clock all the time. After time, I stopped swimming and avoided other physical and social activities because I never knew when the medications would wear off," she said. "Without heavy medication, I could hardly get dressed, get out of bed, or take a shower on my own."

Linda's most notable change after the surgery and treatment at Tiantan Puhua Hospital was her first peaceful full night of sleep in five years. Within 5 weeks after the stem cell implantation, most of Linda's symptoms gradually went away, allowing her medication to be significantly reduced. Details on Linda's treatment are at: http://www.stemcellspuhua.com/articles/article_97730.html.

At the time of this release, two more international Parkinson's sufferers report having significant improvement from the treatment at Tiantan Puhua Hospital. American David Brown, 64, reports better balance, more fluid movement, and the disappearance of "freeze-ups" after his treatment. As well, US citizen James Devlin, 65, from Hawaii, shows significant reduction in his tremors, is feeling increased energy and muscle strength, and is getting more sleep and much more relief from the anxiety and depression he suffered for many years. The experience of both patients is recorded at http://www.stemcellspuhua.com.

About Tiantan Puhua Neurosurgical Hospital

Tiantan (Temple of Heaven) Puhua Neurosurgical Hospital, a world-class international facility in Beijing, is rapidly gaining renown as the world's foremost center for treatment of Parkinson's disease and a range of other neurological disorders through its groundbreaking stem cell therapy. The Hospital collaborates with the Stem Cells Research Center of Peking University, which is the leading stem cells research center in China. There, stem cells are cultured and induced for clinical treatment. To date, Tiantan Puhua Hospital has treated 14 international Parkinson's disease patients. The treatment is based on a clinical trial done at Peking University in which 20 Chinese Parkinson's patients have gone through hRPE stem cells implantation. PET scans done before and after the implantation showed that all patients exhibited increased amounts of dopamine in their brain, with a correlated improvement of movement. Long-term follow-up of the patients remains unavailable and is currently being carefully researched on a selected number of patients. Tiantan Puhua is the only hospital that offers this treatment to patients beyond limited clinical trials. More details about Tiantan Puhua Hospital can be found on the website: http://www.stemcellspuhua.com.

For inquiries, please contact:

Dr. Sherwood Yang - Vice President

Tiantan Puhua Neurosurgical Hospital

12 Tiantan Nanli, Beijing 100050, CHINA

International Department - Tel: +86 132 641 88 915

kotan@stemcellspuhua.com

Also, see http://www.stemcellschina.com for further information.

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Tiantan Puhua Neurosurgical Hospital
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. A disgusting video: U.S. companies sell out Americans
2. Northwestern Mutual, American Family make Computerworlds best IT workplaces
3. Brazilian bio-industry should impress American investors
4. CIO Leadership Series: Byrne Chapman, American Family Insurance
5. Metavante fires 180 North American workers
6. 300 millionth American no cause for eco-alarm
7. American Idol spurs music software
8. Healthcare software addresses "90 million" misclassified Americans
9. Technology and the "American" dream
10. Peters: Innovation the only edge that remains for American business
11. We are American No sex, please
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... Cambridge Semantics, the leading ... today announced that it has been named to The Silicon Review’s “20 Fastest Growing ... other markets, Cambridge Semantics serves the needs of end users facing some of the ...
(Date:4/27/2016)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that ... of United Therapeutics will provide an overview and update ... st Annual Health Care Conference. The ... at 10:00 a.m. Eastern Time, and can be accessed ...
(Date:4/27/2016)... MIAMI (PRWEB) , ... April 27, 2016 , ... ... joined the GSCG Advisory Board. Ross is the founder of GSCG affiliate Kimera Labs ... of Miami, where he studied hematopoietic stem cell transplantation for hematologic disorders and the ...
(Date:4/26/2016)... City, CA (PRWEB) , ... April 26, 2016 ... ... for healthcare, today announced that Ardy Arianpour has joined the company as Chief ... years of experience bringing innovative genomic technologies to market, was most recently Chief ...
Breaking Biology Technology:
(Date:4/26/2016)... LONDON , April 26, 2016 ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... a partnership to integrate the Onegini mobile security ... (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The ... enhanced security to access and transact across channels. ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/31/2016)...  Genomics firm Nabsys has completed a financial  restructuring ... , M.D., who returned to the company in October ... team, including Chief Technology Officer, John Oliver , ... and Vice President of Software and Informatics, Michael ... Dr. Bready served as CEO of Nabsys from 2005-2014 ...
Breaking Biology News(10 mins):